

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.36994202 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 4.36994202 |
| 3 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.28634899 |
| 4 | activated T cell proliferation (GO:0050798) | 4.27785432 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.24203422 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 4.24203422 |
| 7 | alpha-linolenic acid metabolic process (GO:0036109) | 4.23670018 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 4.02686918 |
| 9 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.98144598 |
| 10 | negative T cell selection (GO:0043383) | 3.93912223 |
| 11 | kynurenine metabolic process (GO:0070189) | 3.89735670 |
| 12 | sulfur amino acid catabolic process (GO:0000098) | 3.88840429 |
| 13 | negative thymic T cell selection (GO:0045060) | 3.86906883 |
| 14 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.80845405 |
| 15 | lysine catabolic process (GO:0006554) | 3.77055022 |
| 16 | lysine metabolic process (GO:0006553) | 3.77055022 |
| 17 | complement activation, alternative pathway (GO:0006957) | 3.76717097 |
| 18 | protein carboxylation (GO:0018214) | 3.75434070 |
| 19 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.75434070 |
| 20 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.75303651 |
| 21 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.75303651 |
| 22 | indole-containing compound catabolic process (GO:0042436) | 3.73197189 |
| 23 | indolalkylamine catabolic process (GO:0046218) | 3.73197189 |
| 24 | tryptophan catabolic process (GO:0006569) | 3.73197189 |
| 25 | negative regulation of fibrinolysis (GO:0051918) | 3.72998254 |
| 26 | glyoxylate metabolic process (GO:0046487) | 3.67547509 |
| 27 | urea cycle (GO:0000050) | 3.67525255 |
| 28 | urea metabolic process (GO:0019627) | 3.67525255 |
| 29 | bile acid biosynthetic process (GO:0006699) | 3.67103014 |
| 30 | negative regulation of sterol transport (GO:0032372) | 3.65380953 |
| 31 | negative regulation of cholesterol transport (GO:0032375) | 3.65380953 |
| 32 | regulation of triglyceride catabolic process (GO:0010896) | 3.60164110 |
| 33 | tryptophan metabolic process (GO:0006568) | 3.59458707 |
| 34 | high-density lipoprotein particle remodeling (GO:0034375) | 3.58673437 |
| 35 | amino-acid betaine metabolic process (GO:0006577) | 3.58653728 |
| 36 | positive regulation of CREB transcription factor activity (GO:0032793) | 3.58181583 |
| 37 | interferon-gamma production (GO:0032609) | 3.57653809 |
| 38 | homocysteine metabolic process (GO:0050667) | 3.56629618 |
| 39 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.56052897 |
| 40 | negative regulation of cell killing (GO:0031342) | 3.56052897 |
| 41 | phospholipid homeostasis (GO:0055091) | 3.55408452 |
| 42 | regulation of cholesterol homeostasis (GO:2000188) | 3.54653573 |
| 43 | regulation of protein activation cascade (GO:2000257) | 3.51922109 |
| 44 | nitrogen cycle metabolic process (GO:0071941) | 3.44463813 |
| 45 | plasma lipoprotein particle clearance (GO:0034381) | 3.41460058 |
| 46 | positive T cell selection (GO:0043368) | 3.39491297 |
| 47 | regulation of complement activation (GO:0030449) | 3.35444837 |
| 48 | phospholipid efflux (GO:0033700) | 3.34108068 |
| 49 | cellular response to exogenous dsRNA (GO:0071360) | 3.32825054 |
| 50 | cysteine metabolic process (GO:0006534) | 3.32681592 |
| 51 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.31045392 |
| 52 | pericardium development (GO:0060039) | 3.26128158 |
| 53 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.20306741 |
| 54 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.20306741 |
| 55 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.20306741 |
| 56 | response to interleukin-15 (GO:0070672) | 3.20022952 |
| 57 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.19505347 |
| 58 | L-fucose metabolic process (GO:0042354) | 3.18424908 |
| 59 | L-fucose catabolic process (GO:0042355) | 3.18424908 |
| 60 | fucose catabolic process (GO:0019317) | 3.18424908 |
| 61 | negative regulation of T cell mediated immunity (GO:0002710) | 3.17329232 |
| 62 | regulation of fibrinolysis (GO:0051917) | 3.17256181 |
| 63 | bile acid metabolic process (GO:0008206) | 3.16935413 |
| 64 | reverse cholesterol transport (GO:0043691) | 3.16248337 |
| 65 | cellular response to interleukin-15 (GO:0071350) | 3.13076772 |
| 66 | T cell selection (GO:0045058) | 3.12302463 |
| 67 | positive thymic T cell selection (GO:0045059) | 3.12203173 |
| 68 | protein-lipid complex remodeling (GO:0034368) | 3.11336644 |
| 69 | macromolecular complex remodeling (GO:0034367) | 3.11336644 |
| 70 | plasma lipoprotein particle remodeling (GO:0034369) | 3.11336644 |
| 71 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.11220822 |
| 72 | regulation of cholesterol esterification (GO:0010872) | 3.09217621 |
| 73 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.07165817 |
| 74 | thymic T cell selection (GO:0045061) | 3.06179162 |
| 75 | positive regulation of lipid catabolic process (GO:0050996) | 3.06040295 |
| 76 | 2-oxoglutarate metabolic process (GO:0006103) | 3.05097930 |
| 77 | tolerance induction (GO:0002507) | 3.04953416 |
| 78 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.03846858 |
| 79 | protein-lipid complex assembly (GO:0065005) | 3.02021292 |
| 80 | plasma lipoprotein particle assembly (GO:0034377) | 3.01594440 |
| 81 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.98699811 |
| 82 | regulation of podosome assembly (GO:0071801) | 2.98362436 |
| 83 | low-density lipoprotein particle clearance (GO:0034383) | 2.97701816 |
| 84 | positive regulation of histone deacetylation (GO:0031065) | 2.97541605 |
| 85 | carnitine metabolic process (GO:0009437) | 2.95332219 |
| 86 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.93219834 |
| 87 | serine family amino acid catabolic process (GO:0009071) | 2.93176723 |
| 88 | mannose metabolic process (GO:0006013) | 2.92248333 |
| 89 | regulation of gamma-delta T cell activation (GO:0046643) | 2.89132499 |
| 90 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.88336212 |
| 91 | regulation of cholesterol storage (GO:0010885) | 2.86758996 |
| 92 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.86729619 |
| 93 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.85084282 |
| 94 | behavioral response to nicotine (GO:0035095) | 2.84716451 |
| 95 | cholesterol efflux (GO:0033344) | 2.84031742 |
| 96 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.83251323 |
| 97 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.83251323 |
| 98 | aromatic amino acid family metabolic process (GO:0009072) | 2.82972372 |
| 99 | triglyceride homeostasis (GO:0070328) | 2.82741860 |
| 100 | acylglycerol homeostasis (GO:0055090) | 2.82741860 |
| 101 | cholesterol homeostasis (GO:0042632) | 2.82448965 |
| 102 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.82101500 |
| 103 | regulation of hippo signaling (GO:0035330) | 2.82081643 |
| 104 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.81800682 |
| 105 | drug catabolic process (GO:0042737) | 2.80757002 |
| 106 | tyrosine metabolic process (GO:0006570) | 2.79966829 |
| 107 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.78694746 |
| 108 | sterol homeostasis (GO:0055092) | 2.77672340 |
| 109 | positive regulation of fatty acid oxidation (GO:0046321) | 2.77226041 |
| 110 | bile acid and bile salt transport (GO:0015721) | 2.76791535 |
| 111 | fatty acid beta-oxidation (GO:0006635) | 2.76531518 |
| 112 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.73439454 |
| 113 | apoptotic cell clearance (GO:0043277) | 2.71896134 |
| 114 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.71686419 |
| 115 | histone H3-K4 trimethylation (GO:0080182) | 2.70482913 |
| 116 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.70237652 |
| 117 | ethanol oxidation (GO:0006069) | 2.69650600 |
| 118 | lipoprotein metabolic process (GO:0042157) | 2.69335705 |
| 119 | positive regulation of defense response to virus by host (GO:0002230) | 2.68857399 |
| 120 | fatty acid oxidation (GO:0019395) | 2.67811033 |
| 121 | valine metabolic process (GO:0006573) | 2.66995618 |
| 122 | leukocyte aggregation (GO:0070486) | 2.66917202 |
| 123 | short-chain fatty acid metabolic process (GO:0046459) | 2.66344774 |
| 124 | intestinal cholesterol absorption (GO:0030299) | 2.65490929 |
| 125 | fibrinolysis (GO:0042730) | 2.64906070 |
| 126 | cellular modified amino acid catabolic process (GO:0042219) | 2.63899954 |
| 127 | acetyl-CoA metabolic process (GO:0006084) | 2.63498347 |
| 128 | complement activation, classical pathway (GO:0006958) | 2.62957009 |
| 129 | growth hormone receptor signaling pathway (GO:0060396) | 2.62682321 |
| 130 | complement activation (GO:0006956) | 2.62378685 |
| 131 | regulation of fatty acid oxidation (GO:0046320) | 2.62086329 |
| 132 | tricarboxylic acid metabolic process (GO:0072350) | 2.61985642 |
| 133 | benzene-containing compound metabolic process (GO:0042537) | 2.61791692 |
| 134 | cellular glucuronidation (GO:0052695) | 2.60982438 |
| 135 | lipid oxidation (GO:0034440) | 2.60868347 |
| 136 | alpha-amino acid catabolic process (GO:1901606) | 2.60476621 |
| 137 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.60065816 |
| 138 | negative regulation of lipid transport (GO:0032369) | 2.59768965 |
| 139 | urate metabolic process (GO:0046415) | 2.59364082 |
| 140 | positive regulation of protein deacetylation (GO:0090312) | 2.58832802 |
| 141 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.56121657 |
| 142 | positive regulation of developmental pigmentation (GO:0048087) | 2.51628562 |
| 143 | striated muscle atrophy (GO:0014891) | 2.51185962 |
| 144 | interkinetic nuclear migration (GO:0022027) | 2.50114012 |
| 145 | positive regulation of granulocyte differentiation (GO:0030854) | 2.47360443 |
| 146 | B cell receptor signaling pathway (GO:0050853) | 2.47152120 |
| 147 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.46973517 |
| 148 | regulation of histone deacetylation (GO:0031063) | 2.46528802 |
| 149 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.46109466 |
| 150 | regulation of regulatory T cell differentiation (GO:0045589) | 2.45944322 |
| 151 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.45774416 |
| 152 | protein K48-linked deubiquitination (GO:0071108) | 2.37562480 |
| 153 | regulation of pigment cell differentiation (GO:0050932) | 2.36908118 |
| 154 | cellular extravasation (GO:0045123) | 2.35918890 |
| 155 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.33867650 |
| 156 | regulation of gene silencing by RNA (GO:0060966) | 2.33824330 |
| 157 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.33824330 |
| 158 | regulation of gene silencing by miRNA (GO:0060964) | 2.33824330 |
| 159 | T cell migration (GO:0072678) | 2.32220625 |
| 160 | cellular response to ethanol (GO:0071361) | 2.31612212 |
| 161 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.30566398 |
| 162 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.29741928 |
| 163 | lipid translocation (GO:0034204) | 2.29247957 |
| 164 | phospholipid translocation (GO:0045332) | 2.29247957 |
| 165 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.27411337 |
| 166 | urinary tract smooth muscle contraction (GO:0014848) | 2.27406473 |
| 167 | negative regulation of interleukin-6 production (GO:0032715) | 2.27292193 |
| 168 | negative regulation of myotube differentiation (GO:0010832) | 2.26693776 |
| 169 | regulation of establishment of cell polarity (GO:2000114) | 2.26478951 |
| 170 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.26047544 |
| 171 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.25730163 |
| 172 | establishment of protein localization to Golgi (GO:0072600) | 2.25247582 |
| 173 | macroautophagy (GO:0016236) | 2.21519728 |
| 174 | endocardial cushion development (GO:0003197) | 2.21130697 |
| 175 | cardiovascular system development (GO:0072358) | 2.20801382 |
| 176 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.20515438 |
| 177 | positive regulation of antigen processing and presentation (GO:0002579) | 2.18152332 |
| 178 | positive regulation of cell killing (GO:0031343) | 2.13804057 |
| 179 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.13140831 |
| 180 | endosome to melanosome transport (GO:0035646) | 2.13021382 |
| 181 | endosome to pigment granule transport (GO:0043485) | 2.13021382 |
| 182 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.12763011 |
| 183 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.11762108 |
| 184 | regulation of cell killing (GO:0031341) | 2.11388275 |
| 185 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.11382265 |
| 186 | regulation of antigen processing and presentation (GO:0002577) | 2.10409370 |
| 187 | response to type I interferon (GO:0034340) | 2.10081742 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.46327576 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.72981376 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.36062864 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.88466607 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.76255561 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.35302985 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.89393789 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.87414535 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.52286234 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.48920387 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.48872803 |
| 12 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.35596163 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.30891892 |
| 14 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.29699832 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.26686043 |
| 16 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.26252887 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.24989010 |
| 18 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.22757315 |
| 19 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.17771350 |
| 20 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.10797050 |
| 21 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.06006159 |
| 22 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.02265749 |
| 23 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.95904487 |
| 24 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.93442592 |
| 25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.92753661 |
| 26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.84141037 |
| 27 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.83806081 |
| 28 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.82591484 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.81653002 |
| 30 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.79983712 |
| 31 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.78999392 |
| 32 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.74494312 |
| 33 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.72504447 |
| 34 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.72125140 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.72091917 |
| 36 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.71867345 |
| 37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.70441675 |
| 38 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.69153597 |
| 39 | MAF_26560356_Chip-Seq_TH1_Human | 1.66489159 |
| 40 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.65326257 |
| 41 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.59904475 |
| 42 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.59896766 |
| 43 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.58799460 |
| 44 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.58442662 |
| 45 | TP53_16413492_ChIP-PET_HCT116_Human | 1.57136866 |
| 46 | GATA1_22025678_ChIP-Seq_K562_Human | 1.54774030 |
| 47 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.54502156 |
| 48 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.50203521 |
| 49 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.48703849 |
| 50 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.47841272 |
| 51 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.46604717 |
| 52 | MYC_22102868_ChIP-Seq_BL_Human | 1.46017134 |
| 53 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.44954977 |
| 54 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.42750339 |
| 55 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.41421469 |
| 56 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.38247421 |
| 57 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38061390 |
| 58 | UTX_26944678_Chip-Seq_JUKART_Human | 1.37907366 |
| 59 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.37168891 |
| 60 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.36490661 |
| 61 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34435790 |
| 62 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.33649880 |
| 63 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.32688209 |
| 64 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.32460427 |
| 65 | SPI1_23127762_ChIP-Seq_K562_Human | 1.31777488 |
| 66 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.31075627 |
| 67 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.29164128 |
| 68 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.28496721 |
| 69 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.27367684 |
| 70 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.26919637 |
| 71 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.24936984 |
| 72 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.24702680 |
| 73 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.24655425 |
| 74 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.24456540 |
| 75 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23620117 |
| 76 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.23128088 |
| 77 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.23113326 |
| 78 | * MYB_26560356_Chip-Seq_TH2_Human | 1.19765956 |
| 79 | VDR_22108803_ChIP-Seq_LS180_Human | 1.19308384 |
| 80 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.19298375 |
| 81 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.15676639 |
| 82 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.15648102 |
| 83 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.15456295 |
| 84 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.15404108 |
| 85 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.13277415 |
| 86 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.13030842 |
| 87 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12969575 |
| 88 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.12404024 |
| 89 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11403257 |
| 90 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10954856 |
| 91 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10337076 |
| 92 | * MYB_26560356_Chip-Seq_TH1_Human | 1.10261404 |
| 93 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.09472742 |
| 94 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09167867 |
| 95 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.07841021 |
| 96 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07511645 |
| 97 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.06003198 |
| 98 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.05946867 |
| 99 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.04978315 |
| 100 | GATA3_26560356_Chip-Seq_TH2_Human | 1.04803198 |
| 101 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.04610870 |
| 102 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.03841840 |
| 103 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.03740391 |
| 104 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.03675466 |
| 105 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.02285468 |
| 106 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.02285468 |
| 107 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.02041793 |
| 108 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.01727875 |
| 109 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.01270456 |
| 110 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.00309278 |
| 111 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.99934256 |
| 112 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.99004491 |
| 113 | * MAF_26560356_Chip-Seq_TH2_Human | 0.98519159 |
| 114 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.96330350 |
| 115 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95801812 |
| 116 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.95408629 |
| 117 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94899325 |
| 118 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.94838372 |
| 119 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.94571723 |
| 120 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.94496100 |
| 121 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94403476 |
| 122 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.94367164 |
| 123 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92714441 |
| 124 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.92493697 |
| 125 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.92044250 |
| 126 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.91401615 |
| 127 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.90510304 |
| 128 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.90396913 |
| 129 | STAT3_23295773_ChIP-Seq_U87_Human | 0.90183053 |
| 130 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90116533 |
| 131 | RXR_22108803_ChIP-Seq_LS180_Human | 0.87925654 |
| 132 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.87306947 |
| 133 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.87023327 |
| 134 | ATF3_27146783_Chip-Seq_COLON_Human | 0.86577251 |
| 135 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.86574627 |
| 136 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.86356665 |
| 137 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.86005896 |
| 138 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.85981990 |
| 139 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.85863350 |
| 140 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.85733413 |
| 141 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85355457 |
| 142 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.85236180 |
| 143 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85236180 |
| 144 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.85162395 |
| 145 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.85073506 |
| 146 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.84602455 |
| 147 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.84263123 |
| 148 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.84004688 |
| 149 | * TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.83731568 |
| 150 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.83306639 |
| 151 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.82979637 |
| 152 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.82687473 |
| 153 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.81337030 |
| 154 | TCF4_23295773_ChIP-Seq_U87_Human | 0.80338174 |
| 155 | KDM2B_26808549_Chip-Seq_REH_Human | 0.79979629 |
| 156 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.79929303 |
| 157 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79681998 |
| 158 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.79434286 |
| 159 | ERA_21632823_ChIP-Seq_H3396_Human | 0.79302253 |
| 160 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.78814046 |
| 161 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.78698709 |
| 162 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.78610978 |
| 163 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.78522621 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.18015574 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.36993909 |
| 3 | MP0005365_abnormal_bile_salt | 3.69678476 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.57549945 |
| 5 | MP0009840_abnormal_foam_cell | 2.88268404 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 2.68629588 |
| 7 | MP0003300_gastrointestinal_ulcer | 2.64992716 |
| 8 | MP0003252_abnormal_bile_duct | 2.57697061 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 2.49518539 |
| 10 | MP0000569_abnormal_digit_pigmentation | 2.47895135 |
| 11 | MP0001958_emphysema | 2.39577289 |
| 12 | MP0003279_aneurysm | 2.37258364 |
| 13 | MP0010329_abnormal_lipoprotein_level | 2.35066886 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.23299416 |
| 15 | MP0004043_abnormal_pH_regulation | 2.16052368 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.01969719 |
| 17 | MP0005083_abnormal_biliary_tract | 2.01425941 |
| 18 | MP0005503_abnormal_tendon_morphology | 1.99666619 |
| 19 | MP0003436_decreased_susceptibility_to | 1.98167729 |
| 20 | MP0008961_abnormal_basal_metabolism | 1.96280538 |
| 21 | MP0003646_muscle_fatigue | 1.93410269 |
| 22 | MP0003303_peritoneal_inflammation | 1.91876620 |
| 23 | MP0009384_cardiac_valve_regurgitation | 1.87667120 |
| 24 | MP0005310_abnormal_salivary_gland | 1.85649547 |
| 25 | MP0003195_calcinosis | 1.84827158 |
| 26 | MP0000609_abnormal_liver_physiology | 1.80416722 |
| 27 | MP0003806_abnormal_nucleotide_metabolis | 1.77918885 |
| 28 | MP0001348_abnormal_lacrimal_gland | 1.77682427 |
| 29 | MP0005332_abnormal_amino_acid | 1.77410813 |
| 30 | MP0005058_abnormal_lysosome_morphology | 1.74368521 |
| 31 | MP0001986_abnormal_taste_sensitivity | 1.71822580 |
| 32 | MP0001835_abnormal_antigen_presentation | 1.62708657 |
| 33 | MP0002166_altered_tumor_susceptibility | 1.60927420 |
| 34 | MP0000685_abnormal_immune_system | 1.53356884 |
| 35 | MP0005464_abnormal_platelet_physiology | 1.52686072 |
| 36 | MP0001790_abnormal_immune_system | 1.51151467 |
| 37 | MP0005387_immune_system_phenotype | 1.51151467 |
| 38 | MP0004947_skin_inflammation | 1.51123202 |
| 39 | MP0004381_abnormal_hair_follicle | 1.49635089 |
| 40 | MP0001501_abnormal_sleep_pattern | 1.46905507 |
| 41 | MP0010386_abnormal_urinary_bladder | 1.43674281 |
| 42 | MP0002118_abnormal_lipid_homeostasis | 1.43656108 |
| 43 | MP0002419_abnormal_innate_immunity | 1.41607913 |
| 44 | MP0009643_abnormal_urine_homeostasis | 1.40561144 |
| 45 | MP0005319_abnormal_enzyme/_coenzyme | 1.39296137 |
| 46 | MP0003724_increased_susceptibility_to | 1.38001454 |
| 47 | MP0000230_abnormal_systemic_arterial | 1.37992045 |
| 48 | MP0002138_abnormal_hepatobiliary_system | 1.34705461 |
| 49 | MP0001800_abnormal_humoral_immune | 1.30909228 |
| 50 | MP0005174_abnormal_tail_pigmentation | 1.30322405 |
| 51 | MP0005025_abnormal_response_to | 1.30253903 |
| 52 | MP0000538_abnormal_urinary_bladder | 1.29725855 |
| 53 | MP0004130_abnormal_muscle_cell | 1.29367367 |
| 54 | MP0008469_abnormal_protein_level | 1.28811312 |
| 55 | MP0003172_abnormal_lysosome_physiology | 1.27634115 |
| 56 | MP0010155_abnormal_intestine_physiology | 1.27465199 |
| 57 | MP0000604_amyloidosis | 1.24856513 |
| 58 | MP0004019_abnormal_vitamin_homeostasis | 1.23423798 |
| 59 | MP0006082_CNS_inflammation | 1.21865733 |
| 60 | MP0005670_abnormal_white_adipose | 1.21790916 |
| 61 | MP0001873_stomach_inflammation | 1.21681598 |
| 62 | MP0005595_abnormal_vascular_smooth | 1.21539538 |
| 63 | MP0002452_abnormal_antigen_presenting | 1.21385317 |
| 64 | MP0004142_abnormal_muscle_tone | 1.21358037 |
| 65 | MP0003566_abnormal_cell_adhesion | 1.21133283 |
| 66 | MP0005000_abnormal_immune_tolerance | 1.19950472 |
| 67 | MP0009278_abnormal_bone_marrow | 1.19818171 |
| 68 | MP0010234_abnormal_vibrissa_follicle | 1.19373702 |
| 69 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.19168428 |
| 70 | MP0008438_abnormal_cutaneous_collagen | 1.18585541 |
| 71 | MP0000767_abnormal_smooth_muscle | 1.18576574 |
| 72 | MP0009785_altered_susceptibility_to | 1.16368509 |
| 73 | MP0009333_abnormal_splenocyte_physiolog | 1.13773181 |
| 74 | MP0002723_abnormal_immune_serum | 1.13127898 |
| 75 | MP0001845_abnormal_inflammatory_respons | 1.12942234 |
| 76 | MP0000598_abnormal_liver_morphology | 1.11866700 |
| 77 | MP0000470_abnormal_stomach_morphology | 1.11495456 |
| 78 | MP0005023_abnormal_wound_healing | 1.11298798 |
| 79 | MP0005381_digestive/alimentary_phenotyp | 1.10775436 |
| 80 | MP0002928_abnormal_bile_duct | 1.10447880 |
| 81 | MP0002876_abnormal_thyroid_physiology | 1.09849463 |
| 82 | MP0002168_other_aberrant_phenotype | 1.08992101 |
| 83 | MP0001533_abnormal_skeleton_physiology | 1.08140238 |
| 84 | MP0009764_decreased_sensitivity_to | 1.07237459 |
| 85 | MP0001851_eye_inflammation | 1.06989721 |
| 86 | MP0001664_abnormal_digestion | 1.06856408 |
| 87 | MP0005666_abnormal_adipose_tissue | 1.05820096 |
| 88 | MP0003075_altered_response_to | 1.05733384 |
| 89 | MP0004185_abnormal_adipocyte_glucose | 1.05586258 |
| 90 | MP0005451_abnormal_body_composition | 1.05129076 |
| 91 | MP0001764_abnormal_homeostasis | 1.03705888 |
| 92 | MP0002396_abnormal_hematopoietic_system | 1.03433707 |
| 93 | MP0000703_abnormal_thymus_morphology | 1.03056262 |
| 94 | MP0001819_abnormal_immune_cell | 1.01750827 |
| 95 | MP0009763_increased_sensitivity_to | 1.01588772 |
| 96 | MP0002420_abnormal_adaptive_immunity | 1.01468516 |
| 97 | MP0005275_abnormal_skin_tensile | 1.00731219 |
| 98 | MP0005671_abnormal_response_to | 0.98433027 |
| 99 | MP0000427_abnormal_hair_cycle | 0.97700399 |
| 100 | MP0002006_tumorigenesis | 0.95935253 |
| 101 | MP0003283_abnormal_digestive_organ | 0.94884222 |
| 102 | MP0002998_abnormal_bone_remodeling | 0.94636282 |
| 103 | MP0002254_reproductive_system_inflammat | 0.94517610 |
| 104 | MP0001756_abnormal_urination | 0.94218555 |
| 105 | MP0004883_abnormal_blood_vessel | 0.94067207 |
| 106 | MP0002136_abnormal_kidney_physiology | 0.94002792 |
| 107 | MP0002933_joint_inflammation | 0.92544311 |
| 108 | MP0008872_abnormal_physiological_respon | 0.92396065 |
| 109 | MP0003656_abnormal_erythrocyte_physiolo | 0.91215690 |
| 110 | MP0003763_abnormal_thymus_physiology | 0.90561045 |
| 111 | MP0010352_gastrointestinal_tract_polyps | 0.90008783 |
| 112 | MP0010368_abnormal_lymphatic_system | 0.88376993 |
| 113 | MP0002429_abnormal_blood_cell | 0.88336081 |
| 114 | MP0000465_gastrointestinal_hemorrhage | 0.88202049 |
| 115 | MP0002148_abnormal_hypersensitivity_rea | 0.87528906 |
| 116 | MP0003866_abnormal_defecation | 0.87234986 |
| 117 | MP0003045_fibrosis | 0.87197678 |
| 118 | MP0000015_abnormal_ear_pigmentation | 0.85881274 |
| 119 | MP0001765_abnormal_ion_homeostasis | 0.85727080 |
| 120 | MP0004510_myositis | 0.85456764 |
| 121 | MP0005166_decreased_susceptibility_to | 0.85435202 |
| 122 | MP0003453_abnormal_keratinocyte_physiol | 0.84309009 |
| 123 | MP0005390_skeleton_phenotype | 0.83905186 |
| 124 | MP0003950_abnormal_plasma_membrane | 0.82594769 |
| 125 | MP0003091_abnormal_cell_migration | 0.82533256 |
| 126 | MP0002722_abnormal_immune_system | 0.82479308 |
| 127 | MP0009115_abnormal_fat_cell | 0.81317654 |
| 128 | MP0000716_abnormal_immune_system | 0.81312533 |
| 129 | MP0005636_abnormal_mineral_homeostasis | 0.80531495 |
| 130 | MP0005448_abnormal_energy_balance | 0.79716754 |
| 131 | MP0005164_abnormal_response_to | 0.78952104 |
| 132 | MP0001853_heart_inflammation | 0.78044072 |
| 133 | MP0001502_abnormal_circadian_rhythm | 0.77946011 |
| 134 | MP0003828_pulmonary_edema | 0.77624741 |
| 135 | MP0001881_abnormal_mammary_gland | 0.77469701 |
| 136 | MP0000249_abnormal_blood_vessel | 0.76964260 |
| 137 | MP0009642_abnormal_blood_homeostasis | 0.76594001 |
| 138 | MP0000689_abnormal_spleen_morphology | 0.76530733 |
| 139 | MP0002405_respiratory_system_inflammati | 0.76401387 |
| 140 | MP0005551_abnormal_eye_electrophysiolog | 0.76282889 |
| 141 | MP0000013_abnormal_adipose_tissue | 0.76078159 |
| 142 | MP0002398_abnormal_bone_marrow | 0.75796768 |
| 143 | MP0001243_abnormal_dermal_layer | 0.72958821 |
| 144 | MP0002971_abnormal_brown_adipose | 0.72738350 |
| 145 | MP0001663_abnormal_digestive_system | 0.72116334 |
| 146 | MP0003868_abnormal_feces_composition | 0.71805290 |
| 147 | MP0005167_abnormal_blood-brain_barrier | 0.71492007 |
| 148 | MP0000343_altered_response_to | 0.71026355 |
| 149 | MP0002108_abnormal_muscle_morphology | 0.64340007 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Genetic anticipation (HP:0003743) | 4.71202241 |
| 2 | Deep venous thrombosis (HP:0002625) | 4.71105699 |
| 3 | Xanthomatosis (HP:0000991) | 4.10857287 |
| 4 | Complement deficiency (HP:0004431) | 3.82125564 |
| 5 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.78012044 |
| 6 | Intrahepatic cholestasis (HP:0001406) | 3.68565632 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.63443112 |
| 8 | Clumsiness (HP:0002312) | 3.53303246 |
| 9 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.51716956 |
| 10 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.44500599 |
| 11 | Neonatal hypoglycemia (HP:0001998) | 3.36130367 |
| 12 | Protruding tongue (HP:0010808) | 3.23085676 |
| 13 | Hyperventilation (HP:0002883) | 3.18904205 |
| 14 | Systemic lupus erythematosus (HP:0002725) | 3.16351249 |
| 15 | Hypobetalipoproteinemia (HP:0003563) | 3.15227448 |
| 16 | Myositis (HP:0100614) | 3.11354757 |
| 17 | Hyperlipoproteinemia (HP:0010980) | 3.04590489 |
| 18 | Abnormality of the common coagulation pathway (HP:0010990) | 3.03338941 |
| 19 | Myocardial infarction (HP:0001658) | 3.03149907 |
| 20 | Decreased circulating renin level (HP:0003351) | 3.00410330 |
| 21 | Retrobulbar optic neuritis (HP:0100654) | 3.00010380 |
| 22 | Optic neuritis (HP:0100653) | 3.00010380 |
| 23 | Congenital stationary night blindness (HP:0007642) | 2.97579290 |
| 24 | Abnormality of complement system (HP:0005339) | 2.94860823 |
| 25 | Progressive cerebellar ataxia (HP:0002073) | 2.93243673 |
| 26 | Orchitis (HP:0100796) | 2.89415621 |
| 27 | Recurrent fungal infections (HP:0002841) | 2.87575057 |
| 28 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.87254166 |
| 29 | Joint hemorrhage (HP:0005261) | 2.85853117 |
| 30 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.85253280 |
| 31 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.84789633 |
| 32 | Recurrent cutaneous fungal infections (HP:0011370) | 2.84789633 |
| 33 | Hypoplastic ischia (HP:0003175) | 2.79255141 |
| 34 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.78719638 |
| 35 | Long foot (HP:0001833) | 2.76960437 |
| 36 | Prolonged partial thromboplastin time (HP:0003645) | 2.75315387 |
| 37 | Vacuolated lymphocytes (HP:0001922) | 2.75100041 |
| 38 | Abnormality of T cell number (HP:0011839) | 2.72047049 |
| 39 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.70007679 |
| 40 | Hepatoblastoma (HP:0002884) | 2.68338521 |
| 41 | Ketosis (HP:0001946) | 2.67788192 |
| 42 | Hyperammonemia (HP:0001987) | 2.67568697 |
| 43 | Hypolipoproteinemia (HP:0010981) | 2.64735006 |
| 44 | Broad metatarsal (HP:0001783) | 2.64697605 |
| 45 | Aortic dissection (HP:0002647) | 2.60504215 |
| 46 | Hypoalphalipoproteinemia (HP:0003233) | 2.58636305 |
| 47 | Panhypogammaglobulinemia (HP:0003139) | 2.55551746 |
| 48 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.54267690 |
| 49 | T lymphocytopenia (HP:0005403) | 2.54169770 |
| 50 | Eczematoid dermatitis (HP:0000976) | 2.50943193 |
| 51 | Neoplasm of the adrenal cortex (HP:0100641) | 2.49981058 |
| 52 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.47210000 |
| 53 | Fat malabsorption (HP:0002630) | 2.38349520 |
| 54 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.38223776 |
| 55 | Periodontitis (HP:0000704) | 2.37899173 |
| 56 | Hypercholesterolemia (HP:0003124) | 2.37343668 |
| 57 | Stomach cancer (HP:0012126) | 2.36429521 |
| 58 | Abnormality of the fingertips (HP:0001211) | 2.36003757 |
| 59 | Esophageal varix (HP:0002040) | 2.35832299 |
| 60 | Pustule (HP:0200039) | 2.34227541 |
| 61 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.33727232 |
| 62 | Pancreatic cysts (HP:0001737) | 2.32525220 |
| 63 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.31377865 |
| 64 | Hemoptysis (HP:0002105) | 2.31372988 |
| 65 | Recurrent bronchitis (HP:0002837) | 2.30183828 |
| 66 | Abnormality of purine metabolism (HP:0004352) | 2.27984726 |
| 67 | Abnormal glucose tolerance (HP:0001952) | 2.27930322 |
| 68 | Gingival bleeding (HP:0000225) | 2.26803313 |
| 69 | Epidermoid cyst (HP:0200040) | 2.25257019 |
| 70 | Encephalitis (HP:0002383) | 2.24827791 |
| 71 | Ketoacidosis (HP:0001993) | 2.24469668 |
| 72 | Abnormality of the ischium (HP:0003174) | 2.22574326 |
| 73 | Abnormality of the intrinsic pathway (HP:0010989) | 2.20115355 |
| 74 | Large for gestational age (HP:0001520) | 2.19074756 |
| 75 | Vascular calcification (HP:0004934) | 2.19074600 |
| 76 | Impaired platelet aggregation (HP:0003540) | 2.18903376 |
| 77 | Abnormal platelet function (HP:0011869) | 2.18903376 |
| 78 | Pulmonary infiltrates (HP:0002113) | 2.18690063 |
| 79 | Hypoglycemic coma (HP:0001325) | 2.18381676 |
| 80 | Molar tooth sign on MRI (HP:0002419) | 2.17085889 |
| 81 | Abnormality of midbrain morphology (HP:0002418) | 2.17085889 |
| 82 | Stomatitis (HP:0010280) | 2.15903216 |
| 83 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.15802165 |
| 84 | Autoimmune thrombocytopenia (HP:0001973) | 2.15359486 |
| 85 | Abnormal pancreas size (HP:0012094) | 2.15351845 |
| 86 | Hyperglycinuria (HP:0003108) | 2.14906453 |
| 87 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.14230571 |
| 88 | Abnormality of glycine metabolism (HP:0010895) | 2.14230571 |
| 89 | Gaze-evoked nystagmus (HP:0000640) | 2.14069591 |
| 90 | Attenuation of retinal blood vessels (HP:0007843) | 2.13507181 |
| 91 | Cardiomegaly (HP:0001640) | 2.13369254 |
| 92 | Mitral stenosis (HP:0001718) | 2.12913146 |
| 93 | Fair hair (HP:0002286) | 2.12410347 |
| 94 | Cardiovascular calcification (HP:0011915) | 2.12319660 |
| 95 | Abnormality of nucleobase metabolism (HP:0010932) | 2.11816108 |
| 96 | Aortic regurgitation (HP:0001659) | 2.11324652 |
| 97 | Abnormality of T cells (HP:0002843) | 2.11063626 |
| 98 | Patellar aplasia (HP:0006443) | 2.10667384 |
| 99 | Keratoconjunctivitis (HP:0001096) | 2.10601029 |
| 100 | Diastasis recti (HP:0001540) | 2.10343311 |
| 101 | Bulbous nose (HP:0000414) | 2.10102353 |
| 102 | Recurrent bacterial skin infections (HP:0005406) | 2.09127473 |
| 103 | Axonal loss (HP:0003447) | 2.06939723 |
| 104 | Gout (HP:0001997) | 2.06792254 |
| 105 | Spontaneous hematomas (HP:0007420) | 2.04304350 |
| 106 | Amyloidosis (HP:0011034) | 2.03824652 |
| 107 | Polycythemia (HP:0001901) | 2.03457735 |
| 108 | Prolonged QT interval (HP:0001657) | 2.03274636 |
| 109 | Right ventricular cardiomyopathy (HP:0011663) | 2.03196146 |
| 110 | Hyperglycinemia (HP:0002154) | 2.03050212 |
| 111 | Glomerulonephritis (HP:0000099) | 2.01234000 |
| 112 | Abnormality of iron homeostasis (HP:0011031) | 2.01052582 |
| 113 | Nephritis (HP:0000123) | 1.99972374 |
| 114 | Persistence of primary teeth (HP:0006335) | 1.99885825 |
| 115 | Mucopolysacchariduria (HP:0008155) | 1.99644579 |
| 116 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.99644579 |
| 117 | Gastrointestinal infarctions (HP:0005244) | 1.99564349 |
| 118 | Nonimmune hydrops fetalis (HP:0001790) | 1.98539711 |
| 119 | Chronic hepatic failure (HP:0100626) | 1.97212709 |
| 120 | Keratoconjunctivitis sicca (HP:0001097) | 1.96761532 |
| 121 | Increased mean platelet volume (HP:0011877) | 1.95297834 |
| 122 | Hemiplegia (HP:0002301) | 1.95234613 |
| 123 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.95138978 |
| 124 | Increased connective tissue (HP:0009025) | 1.94570122 |
| 125 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.93989924 |
| 126 | Hematochezia (HP:0002573) | 1.93435672 |
| 127 | Abnormality of methionine metabolism (HP:0010901) | 1.93405452 |
| 128 | Emphysema (HP:0002097) | 1.93404063 |
| 129 | Conjugated hyperbilirubinemia (HP:0002908) | 1.93311355 |
| 130 | Spastic diplegia (HP:0001264) | 1.92813072 |
| 131 | Abnormal platelet volume (HP:0011876) | 1.91580121 |
| 132 | Vasculitis (HP:0002633) | 1.91098050 |
| 133 | Aortic aneurysm (HP:0004942) | 1.91093676 |
| 134 | Tubular atrophy (HP:0000092) | 1.91000189 |
| 135 | Increased cerebral lipofuscin (HP:0011813) | 1.90597726 |
| 136 | Menorrhagia (HP:0000132) | 1.90190180 |
| 137 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.89552912 |
| 138 | Osteolytic defects of the hand bones (HP:0009699) | 1.89552912 |
| 139 | Generalized hypopigmentation of hair (HP:0011358) | 1.88342215 |
| 140 | Inability to walk (HP:0002540) | 1.86924730 |
| 141 | Peritonitis (HP:0002586) | 1.86694743 |
| 142 | Alopecia of scalp (HP:0002293) | 1.86104756 |
| 143 | Abnormality of T cell physiology (HP:0011840) | 1.85918439 |
| 144 | Nephronophthisis (HP:0000090) | 1.85902706 |
| 145 | Recurrent abscess formation (HP:0002722) | 1.84710395 |
| 146 | Hypoplastic nipples (HP:0002557) | 1.84665930 |
| 147 | Upper limb amyotrophy (HP:0009129) | 1.84402424 |
| 148 | Distal upper limb amyotrophy (HP:0007149) | 1.84402424 |
| 149 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.84367083 |
| 150 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.84367083 |
| 151 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.84367083 |
| 152 | Hemorrhage of the eye (HP:0011885) | 1.83682714 |
| 153 | Increased serum ferritin (HP:0003281) | 1.83192345 |
| 154 | IgG deficiency (HP:0004315) | 1.82397134 |
| 155 | Abnormality of the renal medulla (HP:0100957) | 1.81524817 |
| 156 | Hand muscle atrophy (HP:0009130) | 1.80830102 |
| 157 | Abnormality of the nasal mucosa (HP:0000433) | 1.80724588 |
| 158 | Macroglossia (HP:0000158) | 1.79576354 |
| 159 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.79478873 |
| 160 | Diplopia (HP:0000651) | 1.78718119 |
| 161 | Abnormality of binocular vision (HP:0011514) | 1.78718119 |
| 162 | Widely spaced teeth (HP:0000687) | 1.77664728 |
| 163 | Protuberant abdomen (HP:0001538) | 1.77647946 |
| 164 | Cervical subluxation (HP:0003308) | 1.77411272 |
| 165 | Stroke (HP:0001297) | 1.76972317 |
| 166 | Obstructive sleep apnea (HP:0002870) | 1.76357809 |
| 167 | Malnutrition (HP:0004395) | 1.75783593 |
| 168 | Abnormality of macrophages (HP:0004311) | 1.75635562 |
| 169 | Hyperbilirubinemia (HP:0002904) | 1.75173770 |
| 170 | Hypertriglyceridemia (HP:0002155) | 1.74968000 |
| 171 | Abnormality of the renal cortex (HP:0011035) | 1.73404829 |
| 172 | Bicuspid aortic valve (HP:0001647) | 1.71529800 |
| 173 | Progressive inability to walk (HP:0002505) | 1.71471050 |
| 174 | Meningitis (HP:0001287) | 1.71110931 |
| 175 | Colitis (HP:0002583) | 1.70726554 |
| 176 | Chronic otitis media (HP:0000389) | 1.70561636 |
| 177 | Abnormality of the pericardium (HP:0001697) | 1.69462479 |
| 178 | Hypochromic anemia (HP:0001931) | 1.69276715 |
| 179 | Neoplasm of the heart (HP:0100544) | 1.69259711 |
| 180 | Tented upper lip vermilion (HP:0010804) | 1.68297295 |
| 181 | Increased corneal curvature (HP:0100692) | 1.68239167 |
| 182 | Keratoconus (HP:0000563) | 1.68239167 |
| 183 | Congenital sensorineural hearing impairment (HP:0008527) | 1.68087424 |
| 184 | Radial bowing (HP:0002986) | 1.67392898 |
| 185 | Cystic liver disease (HP:0006706) | 1.67129254 |
| 186 | Gingivitis (HP:0000230) | 1.66982311 |
| 187 | Agammaglobulinemia (HP:0004432) | 1.66614747 |
| 188 | Impaired smooth pursuit (HP:0007772) | 1.66238566 |
| 189 | Spondylolisthesis (HP:0003302) | 1.64198685 |
| 190 | Broad ribs (HP:0000885) | 1.64151749 |
| 191 | Long eyelashes (HP:0000527) | 1.64000299 |
| 192 | Abnormal drinking behavior (HP:0030082) | 1.63490693 |
| 193 | Polydipsia (HP:0001959) | 1.63490693 |
| 194 | Inflammation of the large intestine (HP:0002037) | 1.62768550 |
| 195 | Aneurysm (HP:0002617) | 1.62531550 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.31045452 |
| 2 | ERN1 | 3.86153159 |
| 3 | PKN2 | 3.21605808 |
| 4 | FGFR4 | 3.04414669 |
| 5 | SIK1 | 2.90485900 |
| 6 | ACVR1B | 2.86056714 |
| 7 | MAP4K1 | 2.80721372 |
| 8 | RIPK1 | 2.54383928 |
| 9 | EPHB1 | 2.53023488 |
| 10 | PRKG2 | 2.31244429 |
| 11 | TTN | 2.23939071 |
| 12 | AKT3 | 2.06389059 |
| 13 | TYK2 | 2.03994482 |
| 14 | PDK2 | 2.03705197 |
| 15 | TBK1 | 1.99543479 |
| 16 | PTK6 | 1.86381562 |
| 17 | ADRBK2 | 1.76364322 |
| 18 | JAK1 | 1.72163636 |
| 19 | KDR | 1.71727232 |
| 20 | BCKDK | 1.71160195 |
| 21 | MAP3K10 | 1.68825123 |
| 22 | BMPR1B | 1.67511679 |
| 23 | CDC42BPA | 1.65085343 |
| 24 | STK10 | 1.64965725 |
| 25 | ZAP70 | 1.52380744 |
| 26 | TNK2 | 1.49723374 |
| 27 | CAMK1D | 1.47887051 |
| 28 | KIT | 1.45072728 |
| 29 | JAK3 | 1.42829169 |
| 30 | EPHA3 | 1.42271434 |
| 31 | BLK | 1.41301678 |
| 32 | PRKD2 | 1.39097292 |
| 33 | MAP3K7 | 1.36465982 |
| 34 | TAOK3 | 1.36105363 |
| 35 | LRRK2 | 1.33690372 |
| 36 | LMTK2 | 1.33313478 |
| 37 | PIK3CG | 1.31090060 |
| 38 | MST1R | 1.30638179 |
| 39 | ITK | 1.30301397 |
| 40 | GRK6 | 1.28688016 |
| 41 | EEF2K | 1.22809261 |
| 42 | IKBKE | 1.21781811 |
| 43 | ADRBK1 | 1.20139060 |
| 44 | CSK | 1.17256193 |
| 45 | WNK4 | 1.15878155 |
| 46 | MARK2 | 1.15782403 |
| 47 | SIK2 | 1.15481070 |
| 48 | CAMKK2 | 1.13011676 |
| 49 | TGFBR2 | 1.09219146 |
| 50 | FES | 1.08071411 |
| 51 | HIPK2 | 1.06773418 |
| 52 | MAP2K6 | 1.06724184 |
| 53 | STK38 | 1.04793178 |
| 54 | GRK1 | 1.04318765 |
| 55 | MAPK15 | 1.03195719 |
| 56 | CAMK1G | 1.02561775 |
| 57 | CSF1R | 1.02395993 |
| 58 | JAK2 | 1.01536406 |
| 59 | MAP3K14 | 0.99023843 |
| 60 | TLK1 | 0.98441432 |
| 61 | FLT3 | 0.98431241 |
| 62 | MAPKAPK3 | 0.97603055 |
| 63 | MELK | 0.97129982 |
| 64 | STK16 | 0.96045588 |
| 65 | WNK1 | 0.94885300 |
| 66 | RPS6KA6 | 0.92219013 |
| 67 | NEK9 | 0.91473971 |
| 68 | TGFBR1 | 0.90928842 |
| 69 | MAPK11 | 0.89087709 |
| 70 | PAK3 | 0.87235334 |
| 71 | MARK3 | 0.86167409 |
| 72 | DAPK2 | 0.86086737 |
| 73 | FGFR3 | 0.83983769 |
| 74 | TYRO3 | 0.83912587 |
| 75 | SGK2 | 0.82953827 |
| 76 | PDPK1 | 0.78674099 |
| 77 | RIPK4 | 0.78390726 |
| 78 | PDK1 | 0.77664563 |
| 79 | MAP2K3 | 0.77254182 |
| 80 | MAPK12 | 0.76509349 |
| 81 | BTK | 0.75880777 |
| 82 | MAP3K3 | 0.74906475 |
| 83 | FER | 0.74144526 |
| 84 | MYLK | 0.73970984 |
| 85 | RET | 0.73716084 |
| 86 | HCK | 0.71629121 |
| 87 | FRK | 0.71085099 |
| 88 | TIE1 | 0.70107144 |
| 89 | BMX | 0.69977124 |
| 90 | IRAK1 | 0.69854965 |
| 91 | CAMK1 | 0.68437541 |
| 92 | NLK | 0.68107371 |
| 93 | STK11 | 0.67643918 |
| 94 | PTK2 | 0.66995894 |
| 95 | PDGFRA | 0.65884502 |
| 96 | LYN | 0.63510489 |
| 97 | MAPK13 | 0.62423632 |
| 98 | PDGFRB | 0.62061811 |
| 99 | SYK | 0.60796289 |
| 100 | LCK | 0.60642481 |
| 101 | CDK12 | 0.60571865 |
| 102 | RPS6KA2 | 0.60544262 |
| 103 | MAP3K13 | 0.60506818 |
| 104 | PRKAA2 | 0.59130782 |
| 105 | IRAK4 | 0.58261065 |
| 106 | MAP2K2 | 0.57728235 |
| 107 | TRPM7 | 0.54800082 |
| 108 | PAK4 | 0.54544152 |
| 109 | CDK4 | 0.53909238 |
| 110 | MET | 0.53784172 |
| 111 | SGK494 | 0.52681875 |
| 112 | SGK223 | 0.52681875 |
| 113 | MAPK7 | 0.52639010 |
| 114 | MAP2K1 | 0.51862064 |
| 115 | TESK1 | 0.51083011 |
| 116 | PIK3CA | 0.50258436 |
| 117 | RPS6KC1 | 0.49038175 |
| 118 | RPS6KL1 | 0.49038175 |
| 119 | FGFR2 | 0.47600069 |
| 120 | CDK6 | 0.47092149 |
| 121 | CHUK | 0.46852761 |
| 122 | TXK | 0.44350671 |
| 123 | PRKCH | 0.44152833 |
| 124 | MTOR | 0.43235949 |
| 125 | IKBKB | 0.42656158 |
| 126 | EGFR | 0.41804368 |
| 127 | ERBB2 | 0.41326437 |
| 128 | PRKCQ | 0.41260662 |
| 129 | SGK3 | 0.41136627 |
| 130 | ICK | 0.41021998 |
| 131 | MAPK4 | 0.40677429 |
| 132 | INSRR | 0.39706737 |
| 133 | PTK2B | 0.39494361 |
| 134 | DMPK | 0.38503689 |
| 135 | CAMKK1 | 0.38140019 |
| 136 | IGF1R | 0.37851840 |
| 137 | PRKAA1 | 0.37795145 |
| 138 | MAP3K2 | 0.36258934 |
| 139 | TEC | 0.35998239 |
| 140 | TESK2 | 0.35376429 |
| 141 | DYRK1B | 0.35317293 |
| 142 | CAMK2G | 0.34227779 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.54574388 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.06977063 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.93532080 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.59235759 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.55350015 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.53231785 |
| 7 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.45531216 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.42980728 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.33883286 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.27032244 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.07309125 |
| 12 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.06130383 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.88519069 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.87623937 |
| 15 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.87376875 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.84209848 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.78118238 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.70995875 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.66963253 |
| 20 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.65672692 |
| 21 | Bile secretion_Homo sapiens_hsa04976 | 1.65232530 |
| 22 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.62595252 |
| 23 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.62549578 |
| 24 | Allograft rejection_Homo sapiens_hsa05330 | 1.60249172 |
| 25 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.57855168 |
| 26 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.53950610 |
| 27 | Peroxisome_Homo sapiens_hsa04146 | 1.52862775 |
| 28 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.52223469 |
| 29 | Lysine degradation_Homo sapiens_hsa00310 | 1.47499756 |
| 30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.46981577 |
| 31 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.45634580 |
| 32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.45098212 |
| 33 | ABC transporters_Homo sapiens_hsa02010 | 1.41618484 |
| 34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.40127953 |
| 35 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.38795082 |
| 36 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.37669815 |
| 37 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.36546172 |
| 38 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.35344120 |
| 39 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.33177769 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.29741024 |
| 41 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.27553610 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.22363734 |
| 43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.20787401 |
| 44 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.18764569 |
| 45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.18749728 |
| 46 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.18717393 |
| 47 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.17988447 |
| 48 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.16790920 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.16149052 |
| 50 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.14388669 |
| 51 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.13889100 |
| 52 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.10450599 |
| 53 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.09293949 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.08038928 |
| 55 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.07420773 |
| 56 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.06338370 |
| 57 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.05396122 |
| 58 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.04894758 |
| 59 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.02506839 |
| 60 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.98986485 |
| 61 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.97740445 |
| 62 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.95925794 |
| 63 | Phototransduction_Homo sapiens_hsa04744 | 0.95454698 |
| 64 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.95300230 |
| 65 | Insulin resistance_Homo sapiens_hsa04931 | 0.94920665 |
| 66 | Asthma_Homo sapiens_hsa05310 | 0.94420316 |
| 67 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.93565219 |
| 68 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.92509376 |
| 69 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.92440341 |
| 70 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.90095901 |
| 71 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.89463966 |
| 72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.89268687 |
| 73 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.89174768 |
| 74 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.88688019 |
| 75 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.87805886 |
| 76 | Viral myocarditis_Homo sapiens_hsa05416 | 0.87704026 |
| 77 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.86279586 |
| 78 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.86209260 |
| 79 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.84729543 |
| 80 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.83675660 |
| 81 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.83220516 |
| 82 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.82010470 |
| 83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81540610 |
| 84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.81295755 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80820460 |
| 86 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.80202819 |
| 87 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.79464147 |
| 88 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.78991156 |
| 89 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78904899 |
| 90 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.78007304 |
| 91 | Morphine addiction_Homo sapiens_hsa05032 | 0.77916127 |
| 92 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.77756536 |
| 93 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.77361248 |
| 94 | Retinol metabolism_Homo sapiens_hsa00830 | 0.77292596 |
| 95 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.77264715 |
| 96 | Lysosome_Homo sapiens_hsa04142 | 0.76641219 |
| 97 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.75242728 |
| 98 | Leishmaniasis_Homo sapiens_hsa05140 | 0.74972404 |
| 99 | Galactose metabolism_Homo sapiens_hsa00052 | 0.73583027 |
| 100 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73403170 |
| 101 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.71818429 |
| 102 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.70176212 |
| 103 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.69806313 |
| 104 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.68973880 |
| 105 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.67011565 |
| 106 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.66537603 |
| 107 | Focal adhesion_Homo sapiens_hsa04510 | 0.66056519 |
| 108 | Circadian entrainment_Homo sapiens_hsa04713 | 0.65306946 |
| 109 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.65239865 |
| 110 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.64408067 |
| 111 | Other glycan degradation_Homo sapiens_hsa00511 | 0.63512017 |
| 112 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.63227439 |
| 113 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.63010187 |
| 114 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.62877103 |
| 115 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.62351070 |
| 116 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.62005102 |
| 117 | Insulin secretion_Homo sapiens_hsa04911 | 0.61854830 |
| 118 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.61723485 |
| 119 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.61317329 |
| 120 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.61091657 |
| 121 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.60503472 |
| 122 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60017683 |
| 123 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.58174794 |
| 124 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.58077599 |
| 125 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.57337782 |
| 126 | Salivary secretion_Homo sapiens_hsa04970 | 0.57303324 |
| 127 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.56933454 |
| 128 | Renin secretion_Homo sapiens_hsa04924 | 0.56876273 |
| 129 | Measles_Homo sapiens_hsa05162 | 0.56773689 |
| 130 | Circadian rhythm_Homo sapiens_hsa04710 | 0.55512925 |
| 131 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.54584857 |
| 132 | Pertussis_Homo sapiens_hsa05133 | 0.54490633 |
| 133 | Taste transduction_Homo sapiens_hsa04742 | 0.53870551 |
| 134 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.53341472 |
| 135 | Long-term depression_Homo sapiens_hsa04730 | 0.53160714 |
| 136 | Amoebiasis_Homo sapiens_hsa05146 | 0.52277916 |
| 137 | Hepatitis C_Homo sapiens_hsa05160 | 0.51848952 |
| 138 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51422760 |
| 139 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.51104657 |
| 140 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.50547193 |
| 141 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.50493171 |
| 142 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.49862011 |
| 143 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.49037863 |
| 144 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.48633059 |
| 145 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.46337071 |
| 146 | Platelet activation_Homo sapiens_hsa04611 | 0.43830324 |
| 147 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.40381281 |
| 148 | Mineral absorption_Homo sapiens_hsa04978 | 0.39892051 |
| 149 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.39182434 |
| 150 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.36875062 |
| 151 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.35935576 |
| 152 | Influenza A_Homo sapiens_hsa05164 | 0.35114906 |
| 153 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.34291355 |
| 154 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.34126613 |
| 155 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.33959376 |
| 156 | Malaria_Homo sapiens_hsa05144 | 0.32831942 |
| 157 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.31253057 |
| 158 | Tuberculosis_Homo sapiens_hsa05152 | 0.31128405 |
| 159 | Legionellosis_Homo sapiens_hsa05134 | 0.30304193 |
| 160 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.30072797 |
| 161 | Sulfur relay system_Homo sapiens_hsa04122 | 0.29968457 |
| 162 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.29326151 |
| 163 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.29007520 |
| 164 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.28692936 |
| 165 | Apoptosis_Homo sapiens_hsa04210 | 0.28531171 |
| 166 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28251003 |

